Leaflet VIROFOB 245mg film-coated tablets
Indicated for: HIV-1 infection
Route of administration: oral
Substance: tenofovir disoproxil fumarate (antiretroviral)
ATC: J05AF07 (Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors)
This medicine may affect the kidneys.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Tenofovir disoproxil fumarate is an antiviral medication used for the treatment of HIV-1 infection and chronic hepatitis B. It works by inhibiting reverse transcriptase, an enzyme essential for viral replication, thereby reducing the viral load in the body.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be monitored for potential side effects, such as nausea, diarrhea, or headaches. Regular check-ups are also important to monitor kidney function and bone density.
Common side effects include nausea, diarrhea, headaches, and fatigue. In rare cases, severe reactions such as kidney failure or lactic acidosis may occur. Patients should be informed of these risks before starting treatment.
General data about VIROFOB 245mg
- Substance: tenofovir disoproxil fumarate
- Date of latest medicines list: 01-06-2026
- Product code: W62771001
- Concentration: 245mg
- Pharmaceutical form: film-coated tablets
- Quantity: 30
- Product type: Generic medicine
- Price: 576.68 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Compensation lists for VIROFOB 245mg Alvogen
G4 (C1) - Chronic hepatitis of viral etiology (HBV, HCV)
Price
Copayment
Patient
576.68 RON
576.68 RON
0.00 RON
NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment
Price
Copayment
Patient
576.68 RON
576.68 RON
0.00 RON